This compound is a pharmaceutical intermediate designed for use in the manufacturing of complex organic molecules. It features a multi-ring structure with amide, ether, and heterocyclic functional groups, and is supplied as a research compound for synthetic chemistry applications.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 2212021-82-2
5-((S)-2,2-dimethyltetrahydro-2H-pyran-4-yl)-1-((1S,2S)-2-methyl-1-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)cyclopropyl)-1H-indole-2-carboxylic acid
Pharmaceutical intermediate synthesis
Orforglipron Impurity 3
Pharmaceutical intermediate
2,3-DICHLOROQUINOXALINE
Pharmaceutical intermediate for synthesis
(s)-1-(1-(tert-butoxycarbonyl)piperidin-4-yl)pyrrolidine-2-carboxylic acid
Pharmaceutical intermediate for peptide synthesis
3-(4-Fluorophenyl)-2-methylacrylic acid
pharmaceutical intermediate
5-[(4S)-2,2-dimethyloxan-4-yl]-N-methyl-1-[(1S,2S)-2-methyl-1-(5-oxo-4H-1,2,4-oxadiazol-3-yl)cyclopropyl]-N-phenylindole-2-carboxamide
SIYHUHPATYQMMF-YSDGCRRSSA-N
C[C@H]1C[C@]1(C2=NOC(=O)N2)N3C4=C(C=C(C=C4)[C@H]5CCOC(C5)(C)C)C=C3C(=O)N(C)C6=CC=CC=C6
—